Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist Watchlist | Portfolio Portfolio | Dashboard Dashboard
Hi,
Site News
Contact
Market:
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.
Menu

Celularity Inc (CELU)

Celularity Inc (CELU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch Watch
Help
Go To:
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform Business Wire - Thu Aug 27, 8:00AM CDT

Collaboration is intended to expand U.S. manufacturing of Dezawa MuseCells® initially across qualified perinatal sources using the licensed Dezawa Method™ and manufacturing of DMC derived products,...

CELU : 1.9300 (+4.32%)
Celularity Provides Update Regarding Nasdaq Listing Compliance GlobeNewswire - Tue Aug 25, 6:59PM CDT

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it received a notification letter from the Listing Qualifications...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Provides Update Regarding Nasdaq Listing Compliance GlobeNewswire - Tue Aug 25, 6:59PM CDT

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”) today announced that, on August 21, 2026, it...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies GlobeNewswire - Thu Jun 4, 7:00AM CDT

FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies GlobeNewswire - Thu Jun 4, 7:00AM CDT

FLORHAM PARK, N.J. and ORLANDO, Fla., June 04, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Releases CEO Letter to Shareholders GlobeNewswire - Wed Jun 3, 3:15PM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a longevity-focused regenerative and cellular medicine company pioneering placental-derived...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Releases CEO Letter to Shareholders GlobeNewswire - Wed Jun 3, 3:15PM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Appoints Rick Gonzalez as Chief Commercial Officer GlobeNewswire - Wed Jun 3, 7:00AM CDT

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a longevity-focused regenerative and cellular medicine company pioneering...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Appoints Rick Gonzalez as Chief Commercial Officer GlobeNewswire - Wed Jun 3, 7:00AM CDT

Appointment supports Celularity’s focus on longevity, regenerative medicine and preservation of human performance by advancing commercialization of...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)
Celularity Receives Nasdaq Notice Regarding Form 10-Q GlobeNewswire - Fri May 29, 4:15PM CDT

FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular...

CELU : 1.9300 (+4.32%)
CELUW : 0.0019 (+533.33%)

Barchart Exclusives

1 Cheap Stock Under $10 for Aggressive Investors to Buy on the Dip Barchart - 25 minutes ago
Miniso shares hit a multi-year low after weak Q2 2026 results exposed deteriorating overseas profitability. Despite analyst downgrades, a cheap valuation and a new buyback-focused capital return plan make it a speculative rental play, not a long-term hold. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.